AbbVie Shares Drop Over 6% Following Downgrade of Full-Year Profit Guidance

Gelonghui July 29th :: AbbVie (ABBV.US) fell 6.79%, trading at $139.58, with a total market value of $244.6 billion. AbbVie (ABBV.US) reported second-quarter revenue of $14.58 billion, below market expectations of $14.62 billion; adjusted earnings per share were $3.37, surpassing market expectations of $3.32. The company lowered its 2022 adjusted diluted earnings per share from $13.92-$14.12 to $13.78-$13.98, with market expectations at $13.9.